Veillonella

RANK: Genus

TAXONOMY: Bacteria -> Terrabacteria group -> Firmicutes -> Negativicutes -> Selenomonadales -> Veillonellaceae -> Veillonella

OVERVIEW:

'Veillonella' are Gram-negative anaerobic cocci. This bacterium is well known for its lactate fermenting abilities. They are a normal bacterium in the intestines and oral mucosa of mammals. In humans they have been rarely implicated in cases of osteomyelitis and endocarditis, for example with the species Veillonella parvula.Babies with a higher risk of asthma presented lower levels of four bacteria in their feces samples in comparison with the infants who did not show any symptoms. Those bacteria were identified as Faecalibacterium, Lachnospira, Veillonella and Rothia - known all together as FLVR. [http://www.gutmicrobiotawatch.org/en/2015/11/25/four-types-of-gut-bacteria-may-protect-children-against-asthma-risk/]

Cocci, 0.3–0.5 μm in diameter; cells are usually arranged in pairs, masses, or short chains. Stains Gram negative. Nonmotile, nonsporeforming. Anaerobic. Optimum temperature, 30–37°C. Optimum pH, 6.5–8.0. Oxidase negative. Nitrate is reduced. Some species produce an atypical catalase lacking porphyrin. Gas is produced by most strains. Pyruvate, lactate, malate, fumarate, and oxaloacetate are fermented. Carbohydrates and polyols are not fermented by most strains. Major metabolic end products in trypticase-glucose-yeast extract (TGY, see below) broth are acetic and propionic acids. In addition, CO2 and H2 are produced from lactate (Rogosa, 1964). Resident of oral cavity, genito-urinary, respiratory, and intestinal tracts of humans and animals, but can also cause severe human infections such as bacteremia, endocarditis, osteomyelitis, and prosthetic joint infection.

DNA G+C content (mol%): 36–43 (Tm) or 40–44 (Bd).

Type species: Veillonella parvula

This genus contains microbial species that can reside in the human gastrointestinal tract. [PMC 4262072]


Gut associated
Flora/ commensal
Dysbiosis associated
Propionate producer
Microbial Abundance Data: Veillonella
Percent of total population with standard deviation [PMID: 22698087]. Percentages > 1% highlighted.
Buccal
Mucosa
Keratinized
Gingiva
Hard
Palate
Throat
Tonsils
Saliva
Stool
3.674 %
(3.417)
5.570 %
(6.282)
6.440 %
(4.068)
8.543 %
(4.706)
11.100 %
(4.884)
12.945 %
(6.617)
0.070 %
(0.400)
Name
Rank
Client %
Avg %
Avg StdDev
Client StdDev
Veillonella
genus
0.070
0.400
DESCENDANTS
  • Veillonella atypica
  • Veillonella caviae
  • Veillonella criceti
  • Veillonella denticariosi
  • Veillonella dispar
  • Veillonella magna
  • Veillonella montpellierensis
  • Veillonella parvula
  • Veillonella ratti
  • Veillonella rodentium
  • Veillonella rogosae
  • Veillonella seminalis
  • Veillonella sp. 2011_Ileo_VSA_A5
  • Veillonella sp. 2011_Ileo_VSA_C12
  • Veillonella sp. 2011_Ileo_VSA_D1
  • Veillonella sp. 2011_Ileo_VSA_E1
  • Veillonella sp. 2011_Ileo_VSA_E12
  • Veillonella sp. 2011_Ileo_VSA_G9
  • Veillonella sp. 2011_Oral_VSA_B12
  • Veillonella sp. 2011_Oral_VSA_C9
  • Veillonella sp. 2011_Oral_VSA_D12
  • Veillonella sp. 2011_Oral_VSA_D3
  • Veillonella sp. 6_1_27
  • Veillonella sp. ADV 269.01
  • Veillonella sp. ADV 3107.03
  • Veillonella sp. AS16
  • Veillonella sp. CM60
  • Veillonella sp. JL-2
  • Veillonella sp. MSA12
  • Veillonella sp. S101
  • Veillonella sp. oral taxon 780
  • Veillonella tobetsuensis
  • environmental samples
  • INTERACTIONS
    METABOLOMICS   
    Substrates/ Growth Factors
  • Fumarate
  • Lactate
  • Pyruvate
  • Oxalocetate
  • Malate

  • Metabolic Endproducts
  • CO2
  • Propionate
  • H2
  • Acetate

  • Growth Inhibited by
  • Chemotherapy

  • Growth Enhanced By
  • Proton-pump inhibitors (PPI)

  • Biotransforms
  • Daidzein

  • Transform Product
  • Equol sulphate